Western Union and International Money Express clear HSR waiting period for merger

The Hart-Scott-Rodino waiting period for Western Union’s pending acquisition of Intermex expired at 11:59 p.m. ET Monday, removing a key regulatory hurdle. The merger still requires, among other conditions, reinstatement of suspended approval from California’s Department of Financial Protection and Innovation; the companies also recently received approval from New York’s Department of Financial Services. Intermex shares were reported at $9.52, down 40% over six months.

Analysis

The HSR expiration lowers one federal closing risk, but it does not resolve the key residual uncertainty: reinstatement of California approval. The New York commitments also warrant scrutiny for possible constraints on pricing, locations, or service, though their economic burden is not quantified. The immediate effect is mainly a reduction in deal-break risk, not evidence of improved standalone earnings or a higher intrinsic value for either company.

For IMXI, the 40% share-price decline is not by itself a valuation signal in a pending cash-or-stock transaction; the relevant variables are the contractual consideration, current trading spread, closing timetable, and downside if the deal fails. Those terms are absent here, so an unhedged “cheap” thesis is not supported. For Western Union, the strategic upside depends on retaining Intermex’s distribution and customer flows without disrupting them through integration or regulatory restrictions. Competitors such as MoneyGram could benefit if combined operations face execution friction, but no share-gain evidence is provided.

Over days, expect deal-spread repricing to track regulatory headlines. Over 1–3 months, California’s status and closing-condition disclosures are the main catalysts. Over 6–18 months, integration quality and the effect of state commitments on unit economics matter more than today’s procedural milestone. The contrarian point: markets may treat HSR expiry as near-completion, while the remaining state condition can still drive meaningful timing and break risk.

Key Decisions for Investors

• Do not infer a standalone-value floor for IMXI from the cited decline or third-party “undervalued” characterization. Before considering a deal-arbitrage position, verify merger consideration, termination provisions, current deal spread, and expected closing date; size only if the spread compensates for delay and break risk.
• Keep IMXI on a regulatory-event watchlist rather than adding solely on HSR expiry. Reinstatement of California approval would reduce a major residual hurdle; adverse or prolonged California action, or a material change to closing conditions, would falsify the improving-close-probability thesis.
• For WU, treat the transaction as strategically plausible but not yet an earnings catalyst. Monitor disclosures on the New York commitments and post-close integration plans; evidence of restrictions that impair pricing or distribution economics would weaken the deal’s value case.
• Avoid a WU/IMXI pair trade until consideration and exchange mechanics are confirmed. If the deal spread narrows sharply before California clearance, reassess whether the remaining regulatory and timing risk is adequately compensated.